Mechanisms for inhibition of P2 receptors signaling in neural cells

Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides rel...

Full description

Saved in:
Bibliographic Details
Published inMolecular neurobiology Vol. 31; no. 1-3; pp. 65 - 79
Main Authors González, Fernando A, Weisman, Gary A, Erb, Laurie, Seye, Cheikh I, Sun, Grace Y, Velázquez, Betty, Hernández-Pérez, Melvin, Chorna, Nataliya E
Format Journal Article
LanguageEnglish
Published United States Springer Nature B.V 01.01.2005
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides released into the extracellular space from injured or dying neural cells can activate astrocytes via P2 nucleotide receptors. After a brief historical review and update of novel P2 receptor antagonists, this article focuses on recent advancements toward understanding molecular mechanisms that regulate G protein-coupled P2Y receptor signaling. Among P2Y receptor subtypes, the heptahelical P2Y2 nucleotide receptor interacts with vitronectin receptors via an RGD sequence in the first extracellular loop, and this interaction is required for effective signal transduction to activate mitogen-activated protein kinases ERK1/2, to mobilize intracellular calcium stores via activation of phospholipase C, protein kinase C isoforms, and to activate focal adhesion kinase and other signaling events. Ligation of vitronectin receptors with specific antibodies caused an inhibition of P2Y2 receptor-induced ERK1/2 and p38 phosphorylation and P2Y2 receptor-induced cytoskeleton rearrangement and DNA synthesis. Structure-function studies have identified agonist-induced phosphorylation of the C-terminus of the P2Y2 receptor, an important mechanism for receptor desensitization. Understanding selective mechanisms for regulating P2Y2 receptor signaling could provide novel targets for therapeutic strategies in the management of brain injury, synaptogenesis, and neurological disorders.
AbstractList Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides released into the extracellular space from injured or dying neural cells can activate astrocytes via P2 nucleotide receptors. After a brief historical review and update of novel P2 receptor antagonists, this article focuses on recent advancements toward understanding molecular mechanisms that regulate G protein-coupled P2Y receptor signaling. Among P2Y receptor subtypes, the heptahelical P2Y2 nucleotide receptor interacts with vitronectin receptors via an RGD sequence in the first extracellular loop, and this interaction is required for effective signal transduction to activate mitogen-activated protein kinases ERK1/2, to mobilize intracellular calcium stores via activation of phospholipase C, protein kinase C isoforms, and to activate focal adhesion kinase and other signaling events. Ligation of vitronectin receptors with specific antibodies caused an inhibition of P2Y2 receptor-induced ERK1/2 and p38 phosphorylation and P2Y2 receptor-induced cytoskeleton rearrangement and DNA synthesis. Structure-function studies have identified agonist-induced phosphorylation of the C-terminus of the P2Y2 receptor, an important mechanism for receptor desensitization. Understanding selective mechanisms for regulating P2Y2 receptor signaling could provide novel targets for therapeutic strategies in the management of brain injury, synaptogenesis, and neurological disorders.
Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides released into the extracellular space from injured or dying neural cells can activate astrocytes via P2 nucleotide receptors. After a brief historical review and update of novel P2 receptor antagonists, this article focuses on recent advancements toward understanding molecular mechanisms that regulate G protein-coupled P2Y receptor signaling. Among P2Y receptor subtypes, the heptahelical P2Y^sub 2^ nucleotide receptor interacts with vitronectin receptors via an RGD sequence in the first extracellular loop, and this interaction is required for effective signal transduction to activate mitogen-activated protein kinases ERK1/2, to mobilize intracellular calcium stores via activation of phospholipase C, protein kinase C isoforms, and to activate focal adhesion kinase and other signaling events. Ligation of vitronectin receptors with specific antibodies caused an inhibition of P2Y^sub 2^ receptor-induced ERK1/2 and p38 phosphorylation and P2Y^sub 2^ receptor-induced cytoskeleton rearrangement and DNA synthesis. Structure-function studies have identified agonist-induced phosphorylation of the C-terminus of the P2Y^sub 2^ receptor, an important mechanism for receptor desensitization. Understanding selective mechanisms for regulating P2Y^sub 2^ receptor signaling could provide novel targets for therapeutic strategies in the management of brain injury, synaptogenesis, and neurological disorders.[PUBLICATION ABSTRACT]
Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides released into the extracellular space from injured or dying neural cells can activate astrocytes via P2 nucleotide receptors. After a brief historical review and update of novel P2 receptor antagonists, this article focuses on recent advancements toward understanding molecular mechanisms that regulate G protein-coupled P2Y receptor signaling. Among P2Y receptor subtypes, the heptahelical P2Y sub(2) nucleotide receptor interacts with vitronectin receptors via an RGD sequence in the first extracellular loop, and this interaction is required for effective signal transduction to activate mitogen-activated protein kinases ERK1/2, to mobilize intracellular calcium stores via activation of phospholipase C, protein kinase C isoforms, and to activate focal adhesion kinase and other signaling events. Ligation of vitronectin receptors with specific antibodies caused an inhibition of P2Y sub(2) receptor-induced ERK1/2 and p38 phosphorylation and P2Y sub(2) receptor-induced cytoskeleton rearrangement and DNA synthesis. Structure-function studies have identified agonist-induced phosphorylation of the C-terminus of the P2Y sub(2) receptor, an important mechanism for receptor desensitization. Understanding selective mechanisms for regulating P2Y sub(2) receptor signaling could provide novel targets for therapeutic strategies in the management of brain injury, synaptogenesis, and neurological disorders.
Author Seye, Cheikh I
Erb, Laurie
Velázquez, Betty
González, Fernando A
Sun, Grace Y
Hernández-Pérez, Melvin
Chorna, Nataliya E
Weisman, Gary A
Author_xml – sequence: 1
  givenname: Fernando A
  surname: González
  fullname: González, Fernando A
  email: fgonzal@u.pracd.upr.clu.edu
  organization: Department of Chemistry, University of Puerto Rico, Río Piedras Campus, Puerto Rico. fgonzal@u.pracd.upr.clu.edu
– sequence: 2
  givenname: Gary A
  surname: Weisman
  fullname: Weisman, Gary A
– sequence: 3
  givenname: Laurie
  surname: Erb
  fullname: Erb, Laurie
– sequence: 4
  givenname: Cheikh I
  surname: Seye
  fullname: Seye, Cheikh I
– sequence: 5
  givenname: Grace Y
  surname: Sun
  fullname: Sun, Grace Y
– sequence: 6
  givenname: Betty
  surname: Velázquez
  fullname: Velázquez, Betty
– sequence: 7
  givenname: Melvin
  surname: Hernández-Pérez
  fullname: Hernández-Pérez, Melvin
– sequence: 8
  givenname: Nataliya E
  surname: Chorna
  fullname: Chorna, Nataliya E
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15953812$$D View this record in MEDLINE/PubMed
BookMark eNp90T1PwzAQBmALgSgFRlYUMcAUOPsSx-6GKr6ktjDAbDmpTY1Su9jNwL8nVSuBGJjuhkev7mNI9n3whpAzCtcURXkznY2QjmiOI-DlHjkCITGveCH2f_UDMkzpA4AxCtUhGdBSligoOyLjqWkW2ru0TJkNMXN-4Wq3dsFnwWYvLIumMat1iClL7t3r1vn3HmXedFG3WWPaNp2QA6vbZE539Zi83d-9jh_zyfPD0_h2kjdYleucykIDIhS6ZihqWVhr5rYRhhYSGC9KwTloYZAKhmCFrJrKIlKNALKWHI_J1TZ3FcNnZ9JaLV3aTKC9CV1SggNWrCygl5f_Sl7JPhg2kRd_4EfoYr9mUowWAigvWY_yLWpiSCkaq1bRLXX8UhTU5glqOlNIFVWo-if0_nwX2tVLM__Ru6vjN4NOgQM
CitedBy_id crossref_primary_10_1096_fj_201701064RR
crossref_primary_10_1104_pp_110_162503
crossref_primary_10_1080_02772240701382131
crossref_primary_10_1021_bi051517w
crossref_primary_10_1523_JNEUROSCI_5338_05_2006
crossref_primary_10_1007_s00702_008_0067_y
crossref_primary_10_1097_01_fpc_0000189798_11468_6a
crossref_primary_10_4049_jimmunol_178_2_720
crossref_primary_10_1177_039463200702000210
crossref_primary_10_1016_j_resp_2008_04_020
crossref_primary_10_1007_s12035_012_8263_z
crossref_primary_10_1007_s00424_006_0071_8
crossref_primary_10_1007_s11302_006_9035_x
crossref_primary_10_1152_ajpcell_00100_2009
crossref_primary_10_1002_jcp_20946
crossref_primary_10_1016_j_mehy_2006_01_010
crossref_primary_10_1111_dgd_12156
crossref_primary_10_4049_jimmunol_179_9_6016
crossref_primary_10_1177_039463200601900207
ContentType Journal Article
Copyright Humana Press Inc. 2005
Copyright_xml – notice: Humana Press Inc. 2005
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QR
7TK
7X7
7XB
88A
88E
88G
88I
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M2P
M7P
P64
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
DOI 10.1385/MN:31:1-3:065
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Chemoreception Abstracts
Neurosciences Abstracts
Health Medical collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Psychology Database (ProQuest)
Science Journals (ProQuest Database)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Psychology
ProQuest Central Student
Technology Research Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
Chemoreception Abstracts
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
ProQuest One Psychology
Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 0893-7648
1559-1182
EndPage 79
ExternalDocumentID 1940183381
10_1385_MN_31_1_3_065
15953812
Genre Research Support, U.S. Gov't, P.H.S
Review
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCRR NIH HHS
  grantid: P20 RR-15565
– fundername: NIGMS NIH HHS
  grantid: S06 GM-08102
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
-~X
.86
.GJ
.VR
06C
06D
0R~
0VY
123
1N0
2.D
203
28-
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3SX
3V.
4.4
406
408
40D
40E
53G
5VS
67N
6NX
78A
7X7
88A
88E
88I
8AO
8CJ
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAEOY
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAQLM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIVO
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACCUX
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADOJD
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIZAD
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CS3
CSCUP
CUY
CVF
D1J
DDRTE
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
ECM
EIF
EIOEI
EJD
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
H13
HCIFZ
HF~
HG6
HMCUK
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
ITM
IWAJR
IXC
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KDC
KOV
LK8
LLZTM
M0L
M1P
M2M
M2P
M4Y
M7P
MA-
N2Q
N9A
NDZJH
NF0
NPM
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PSYQQ
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK6
WK8
XJT
YLTOR
Z7U
Z7W
Z82
Z83
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
~EX
~KM
AAYXX
ADOAH
CITATION
7QR
7TK
7XB
8FD
8FK
FR3
K9.
P64
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c375t-194a03304ab238b94ffedfc8e149026458660a8e318230f897c7f331a3009b963
IEDL.DBID BENPR
ISSN 0893-7648
IngestDate Fri Oct 25 02:33:33 EDT 2024
Thu Oct 24 23:52:08 EDT 2024
Thu Oct 10 16:43:26 EDT 2024
Thu Sep 12 17:35:14 EDT 2024
Tue Oct 15 23:30:41 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1-3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-194a03304ab238b94ffedfc8e149026458660a8e318230f897c7f331a3009b963
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Feature-1
PMID 15953812
PQID 214801652
PQPubID 55365
PageCount 15
ParticipantIDs proquest_miscellaneous_860372540
proquest_miscellaneous_67933106
proquest_journals_214801652
crossref_primary_10_1385_MN_31_1_3_065
pubmed_primary_15953812
PublicationCentury 2000
PublicationDate 2005-01-01
PublicationDateYYYYMMDD 2005-01-01
PublicationDate_xml – month: 01
  year: 2005
  text: 2005-01-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Totowa
PublicationTitle Molecular neurobiology
PublicationTitleAlternate Mol Neurobiol
PublicationYear 2005
Publisher Springer Nature B.V
Publisher_xml – name: Springer Nature B.V
References 9257926 - Br J Pharmacol. 1997 Aug;121(7):1445-53
12586354 - FEBS Lett. 2003 Feb 11;536(1-3):145-50
11734618 - Pharmacol Rev. 2001 Dec;53(4):553-68
11099776 - Neurochem Int. 2001 Mar;38(3):189-97
2818584 - Biochem Biophys Res Commun. 1989 Oct 31;164(2):706-13
14514872 - J Physiol. 2003 Dec 15;553(Pt 3):683-94
4270904 - Biochim Biophys Acta. 1973 Oct 5;320(3):635-47
10821429 - Mol Cell Biochem. 2000 Feb;205(1-2):115-23
8895885 - Neuroscience. 1996 Oct;74(4):1187-96
11521173 - Naunyn Schmiedebergs Arch Pharmacol. 2001 Sep;364(3):285-90
9614197 - Mol Pharmacol. 1998 Jun;53(6):969-73
10471087 - Neuropharmacology. 1999 Sep;38(9):1335-42
2555322 - J Biol Chem. 1989 Nov 25;264(33):19535-9
9723959 - Br J Pharmacol. 1998 Aug;124(7):1463-6
12672232 - J Med Chem. 2003 Apr 10;46(8):1318-29
10788429 - J Biol Chem. 2000 May 5;275(18):13243-9
12787824 - Eur J Pharmacol. 2003 May 30;470(1-2):1-7
8787135 - Trends Neurosci. 1996 Jan;19(1):13-8
11111826 - Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):310-23
8159738 - Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3275-9
12660218 - J Leukoc Biol. 2003 Apr;73(4):442-7
12694404 - J Neurochem. 2003 May;85(3):779-90
2895645 - Biochem Biophys Res Commun. 1988 Mar 30;151(3):1205-12
6214553 - J Biol Chem. 1982 Oct 10;257(19):11510-6
2592429 - J Cell Physiol. 1989 Dec;141(3):606-17
1348186 - Biochemistry. 1992 Mar 31;31(12):3193-7
3259582 - J Cell Physiol. 1988 May;135(2):269-76
8515840 - Neuroscience. 1993 May;54(1):15-36
15379893 - J Neurochem. 2004 Oct;91(1):119-32
1712731 - Exp Cell Res. 1991 Aug;195(2):368-75
14522842 - Br J Pharmacol. 2003 Oct;140(3):507-19
11267999 - J Cell Physiol. 2001 May;187(2):196-208
9530930 - Neurosci Lett. 1998 Feb 20;242(3):159-62
1850750 - J Cell Physiol. 1991 Mar;146(3):483-94
12482951 - Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17179-84
10869734 - J Auton Nerv Syst. 2000 Jul 3;81(1-3):289-94
12849743 - Neuroscience. 2003;120(1):85-98
1358898 - J Cell Physiol. 1992 Nov;153(2):221-33
14567069 - Vascul Pharmacol. 2002 Dec;39(6):309-15
9416670 - Trends Neurosci. 1997 Dec;20(12):570-7
11171941 - Pharmacol Rev. 2001 Mar;53(1):107-18
11831909 - J Med Chem. 2002 Feb 14;45(4):962-72
10551009 - Prog Brain Res. 1999;120:333-42
14523092 - J Neurosci. 2003 Oct 1;23 (26):8903-10
2813367 - Proc Natl Acad Sci U S A. 1989 Oct;86(20):7904-8
4053038 - Cancer Res. 1985 Nov;45(11 Pt 2):5663-9
12437584 - J Neurochem. 2002 Dec;83(5):1129-38
2708449 - J Cell Physiol. 1989 Apr;139(1):109-15
14623769 - Br J Pharmacol. 2003 Dec;140(8):1381-8
11256077 - Nat Rev Neurosci. 2001 Mar;2(3):165-74
12098642 - Neurosci Lett. 2002 Jul 19;327(2):87-90
15024037 - J Pharmacol Exp Ther. 2004 Jul;310(1):407-16
11111827 - Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):324-39
2175913 - Proc Natl Acad Sci U S A. 1990 Dec;87(24):9717-21
15953819 - Mol Neurobiol. 2005;31(1-3):169-83
12236792 - Bioconjug Chem. 2002 Sep-Oct;13(5):1100-11
9597157 - Annu Rev Pharmacol Toxicol. 1998;38:289-319
11099777 - Neurochem Int. 2001 Mar;38(3):199-207
2022702 - J Cell Physiol. 1991 Mar;146(3):473-82
11292387 - Cell Calcium. 2001 May;29(5):299-309
14522840 - Br J Pharmacol. 2003 Oct;140(3):441-3
8579591 - Biochem Biophys Res Commun. 1996 Jan 26;218(3):783-8
9599406 - Semin Cell Dev Biol. 1998 Apr;9(2):119-27
11871639 - Clin Med (Lond). 2002 Jan-Feb;2(1):45-53
10570953 - FEBS Lett. 1999 Sep 24;458(3):424-8
9755289 - Pharmacol Rev. 1998 Sep;50(3):413-92
198725 - Pain. 1977 Aug;3(4):367-77
9792648 - J Biol Chem. 1998 Nov 6;273(45):29437-44
2264825 - Biochem J. 1990 Nov 15;272(1):217-21
10727719 - Neuropharmacology. 2000 Apr 3;39(6):1083-94
12270951 - Physiol Rev. 2002 Oct;82(4):1013-67
10551008 - Prog Brain Res. 1999;120:323-32
9521483 - Naunyn Schmiedebergs Arch Pharmacol. 1998 Feb;357(2):111-20
12595918 - Cardiovasc Drug Rev. 2003 Spring;21(1):67-76
11056181 - Brain Res. 2000 Nov 3;882(1-2):26-35
10836147 - Annu Rev Pharmacol Toxicol. 2000;40:563-80
11959804 - Br J Pharmacol. 2002 Apr;135(8):2004-10
11331301 - J Cell Biol. 2001 Apr 30;153(3):491-501
11093790 - Mol Pharmacol. 2000 Dec;58(6):1502-10
14670955 - J Biol Chem. 2004 Feb 27;279(9):8212-8
10341225 - J Neurosci. 1999 Jun 1;19(11):4211-20
12588784 - Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):357-62
9113369 - Br J Pharmacol. 1997 Apr;120(8):1483-90
11707406 - EMBO J. 2001 Nov 15;20(22):6347-58
11171937 - Pharmacol Rev. 2001 Mar;53(1):1-24
15001573 - J Biol Chem. 2004 May 7;279(19):19790-9
7819532 - Neuroreport. 1994 Aug 15;5(13):1617-20
References_xml
SSID ssj0022107
Score 1.8695753
SecondaryResourceType review_article
Snippet Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 65
SubjectTerms Animals
Benzenesulfonates - pharmacology
Cells
Humans
Kinases
Neurological disorders
Neurons
Neurons - cytology
Neurons - drug effects
Neurons - physiology
Proteins
Purinergic P2 Receptor Agonists
Purinergic P2 Receptor Antagonists
Receptors, Purinergic P2 - physiology
Signal transduction
Signal Transduction - drug effects
Signal Transduction - physiology
Studies
Title Mechanisms for inhibition of P2 receptors signaling in neural cells
URI https://www.ncbi.nlm.nih.gov/pubmed/15953812
https://www.proquest.com/docview/214801652
https://search.proquest.com/docview/67933106
https://search.proquest.com/docview/860372540
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTxsxEB5BcumlKqWPFJr6UHGzsNfvXFCCiBBSVqgqUm6W92E1BzahGw7994w3m7QXeral9fox833j8TcA35mIMSiuqQ1SUFlaQYPLkoqotBWTwZVFeu-8yPXtg7xbqmWfm9P2aZV7m9gZ6mpdphj5ZcaT0IlW2dXmiaaiUelyta-gcQxDbGZsAMPZTX7_48C4kM_spD6doEZL24tsCqsuF_lE8AmnYsKSY_nXKb2CNDuPM38Hb3uoSKa7tT2Bo7p5D6fTBmny4x9yQbrkzS4qfgrXizo94V21jy1BGEpWza9V0WVjkXUk9xlBw1ZvUmUdkjI2QnqEjp1IkrPEb6TwffsBHuY3P69vaV8fgZbCqC3lTgaW4hGhQMdbOBljXcXS1sh6kFpJZbVmwaYoJxKNaJ0pTRSCB4HAqsCT9xEGzbqpPwNhxpTOxsijjNIFEVSwVlcIXmQlS8NGcLGfIL_ZyWD47i7MKr_IveCee-FxJkdwtp8-35-G1h_WbgTfDq24jdPPhaZeP7deo51ApKlHQF7pYTUTBuksjuXTbln-jkQ5tNs8-_Lfj5_Bm053tYufnMNg-_u5_oqIYluM4dgszRiG0_lslo_7XfQCItvKOw
link.rule.ids 315,783,787,12068,21400,27936,27937,31731,31732,33756,33757,43322,43817,74073,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB5RONBL1RZaFtriQ8XNIo4fsfdSAQJtKYlQBRI3y3lY7IHs0iwH_n1nstktF3qOJTt-zHzfePwNwPdExhi0MNwGJbmqrOTBpaQiqmydqOCqkt4754WZ3KrLO3035OZ0Q1rlyib2hrqeVRQjP04FCZ0Ynf6YP3IqGkWXq0MFjTewRUpVyL22Ts-L699rxoV8Zin16STPjLKDyKa0-jgvxlKMBZfjhBzLS6f0CtLsPc7Fe3g3QEV2slzbD7DRtB9h56RFmvzwzI5Yn7zZR8V34Cxv6AnvtHvoGMJQNm3vp2WfjcVmkV2nDA1bM6fKOowyNgI9QsdGjOQssQ8K33e7cHtxfnM24UN9BF7JTC-4cCokFI8IJTre0qkYmzpWtkHWg9RKaWtMEixFOZFoROuyKotSiiARWJV48j7BZjtrmz1gSZZVzsYooorKBRl0sNbUCF5UraosGcHRaoL8fCmD4fu7MKt9XngpvPDS40yO4GA1fX44DZ1fr90IDtdfcRvTz4W2mT113qCdQKRpRsBeaWFNIjOksziWz8tl-TcS7dBui3T_v50fwvbkJr_yVz-LXwfwttdg7WMpX2Bz8eep-YroYlF-G_bQX8xfytI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxEB5BKiEuCCiPtEB9QL1ZsdfvXFApjcojqwhRqTfL-7DIoZvQTQ_8e8YbJ3Ap57Vkrx8z3zcefwPwnokYg-Ka2iAFlbUVNLgiqYhK2zAZXF2l987zUl9eyS_X6jpLCvU5rXJnEwdD3azqFCOfFDwJnWhVTGLOilh8mn1Y_6KpgFS6aM3VNB7CgZFasBEcfLwoF9_37Au5zVb20wlqtLRZcFNYNZmXU8GnnIopS07mXwd1D-ocvM_sKTzJsJGcbdf5GTxou-dweNYhZb75TU7JkMg5RMgP4Xzepue8y_6mJwhJybL7uayGzCyyimRREDRy7TpV2SEpeyOkB-nYiCRpS-wjhfL7F3A1u_hxfklzrQRaC6M2lDsZWIpNhAqdcOVkjG0Ta9siA0KaJZXVmgWbIp5IOqJ1pjZRCB4EgqwKT-FLGHWrrn0NhBlTOxsjjzJKF0RQwVrdIJCRjawNG8PpboL8eiuJ4Yd7Mav8vPSCe-6Fx5kcw_Fu-nw-Gb3fr-MYTvZfcUunnwtdu7rrvUabgahTj4Hc08JqJgxSWxzLq-2y_B2JcmjDeXH0385P4BFuH__tc_n1GB4PcqxDWOUNjDa3d-1bBBqb6l3eQn8AQzPPAA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanisms+for+inhibition+of+P2+receptors+signaling+in+neural+cells&rft.jtitle=Molecular+neurobiology&rft.au=Gonz%C3%A1lez%2C+Fernando+A&rft.au=Weisman%2C+Gary+A&rft.au=Erb%2C+Laurie&rft.au=Seye%2C+Cheikh+I&rft.date=2005-01-01&rft.pub=Springer+Nature+B.V&rft.issn=0893-7648&rft.eissn=1559-1182&rft.volume=31&rft.issue=1-3&rft.spage=65&rft_id=info:doi/10.1385%2FMN%3A31%3A1-3%3A065&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=1940183381
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-7648&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-7648&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-7648&client=summon